Revolution Medicines, Inc. · NASDAQ:RVMD
Giauque, Nicolas reported a 6.90% stake in Revolution Medicines, Inc. (Schedule 13G/A)
Event Sep 30, 2024 · Filed May 15, 2025
Giauque, Nicolas reported a 6.90% stake in Revolution Medicines, Inc., 11,331,045 shares, as a passive investor on Sep 30, 2024. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 6.90%
- Shares
- 11,331,045
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 29 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Farallon Capital Partners, L.P. | 0.50% | 816,794 |
| Farallon Capital Institutional Partners, L.P. | 0.60% | 1,016,234 |
| Farallon Capital Institutional Partners II, L.P. | 0.20% | 280,341 |
| Farallon Capital Institutional Partners III, L.P. | 0.10% | 110,363 |
| Four Crossings Institutional Partners V, L.P. | 0.10% | 177,102 |
| Farallon Capital Offshore Investors II, L.P. | 1.10% | 1,846,861 |
| Farallon Capital (AM) Investors, L.P. | 0.10% | 110,680 |
| Farallon Capital F5 Master I, L.P. | 0.20% | 408,085 |
| Farallon Healthcare Partners Master, L.P. | 3.90% | 6,564,585 |
| Farallon Partners, L.L.C. | 6.50% | 10,922,960 |
| Farallon Institutional (GP) V, L.L.C. | 0.10% | 177,102 |
| Farallon F5 (GP), L.L.C. | 0.20% | 408,085 |
| Farallon Healthcare Partners (GP), L.L.C. | 3.90% | 6,564,585 |
| Dapice Joshua J. | 6.80% | 11,331,045 |
| Dreyfuss, Philip D. | 6.80% | 11,331,045 |
| Dunn Hannah E. | 6.80% | 11,331,045 |
| Fried, Richard B | 6.80% | 11,331,045 |
| Gehani, Varun N. | 6.80% | 11,331,045 |
| Giauque, Nicolas | 6.90% | 11,331,045 |
| Kim, David T. | 6.80% | 11,331,045 |
| Linn, Michael G. | 6.80% | 11,331,045 |
| Patel, Rajiv A. | 6.80% | 11,331,045 |
| Roberts, Jr., Thomas G. | 6.80% | 11,331,045 |
| Saito Edric C. | 6.80% | 11,331,045 |
| Seybold, William | 6.80% | 11,331,045 |
| Short Daniel S. | 6.80% | 11,331,045 |
| Spokes, Andrew J. M. | 6.80% | 11,331,045 |
| Warren, John R. | 6.80% | 11,331,045 |
| Wehrly, Mark C. | 6.80% | 11,331,045 |
Source
Related
- Revolution Medicines, Inc.
- Dapice Joshua J.
- Revolution Medicines, Inc. shareholders
- Schedule 13G/A · Dapice Joshua J. · Feb 9, 2026
- Schedule 13G · Dapice Joshua J. · May 15, 2025
- Schedule 13G/A · Dapice Joshua J. · May 15, 2025
- Form 4 · Sandler Alan B. · Oct 1, 2026
- Form 4 · Cislini Jeff · Sep 29, 2026
- Form 4 · Mancini Anthony · Sep 28, 2026
- Form 4 · Anderson Elizabeth M · Sep 24, 2026
- Form 4 · Mancini Anthony · Sep 22, 2026